Chi Sheng Pharma & Biotech , Ltd Profit Margin

As of the most recent data (June 2026), 4111.TWO shows a profit margin of 13.31%. That compares with 10.77% in the prior-year period — up 23.5% year over year. That is above the sector sector average of 13.09%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4111.TWO's profit margin is now 13.31% (was 10.77%) — a 23.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Chi Sheng Pharma & Biotech , Ltd is outperforming or lagging.

The its sector sector average profit margin is about 13.09%. Chi Sheng Pharma & Biotech , Ltd is at 13.31%, which is higher that average. That is roughly 1.7% above the sector mean. Use the comparison chart on this page to see how 4111.TWO stacks up against individual peers as well.

That compares with 10.77% in the prior-year period — up 23.5% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Chi Sheng Pharma & Biotech , Ltd with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Chi Sheng Pharma & Biotech , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 13.31%) with ownership activity and broader fundamentals.